Viewing Study NCT07288359


Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2025-12-25 @ 3:14 PM
Study NCT ID: NCT07288359
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module